Mirae Asset Global Investments’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $979K | Buy |
6,452
+334
| +5% | +$50.7K | ﹤0.01% | 836 |
|
|
2025
Q1 | $952K | Buy |
6,118
+817
| +15% | +$127K | ﹤0.01% | 822 |
|
|
2024
Q4 | $987K | Buy |
5,301
+1,679
| +46% | +$313K | ﹤0.01% | 820 |
|
|
2024
Q3 | $718K | Sell |
3,622
-1,137
| -24% | -$225K | ﹤0.01% | 891 |
|
|
2024
Q2 | $987K | Sell |
4,759
-5,954
| -56% | -$1.23M | ﹤0.01% | 766 |
|
|
2024
Q1 | $2.6M | Sell |
10,713
-4,045
| -27% | -$980K | 0.01% | 1071 |
|
|
2023
Q4 | $3.5M | Sell |
14,758
-638
| -4% | -$151K | 0.01% | 1025 |
|
|
2023
Q3 | $3.01M | Sell |
15,396
-3,693
| -19% | -$721K | 0.01% | 1017 |
|
|
2023
Q2 | $4M | Buy |
19,089
+479
| +3% | +$100K | 0.01% | 956 |
|
|
2023
Q1 | $3.72M | Buy |
18,610
+2,207
| +13% | +$442K | 0.01% | 949 |
|
|
2022
Q4 | $3.61M | Buy |
16,403
+4,123
| +34% | +$908K | 0.01% | 922 |
|
|
2022
Q3 | $2.38M | Buy |
+12,280
| New | +$2.38M | 0.01% | 1064 |
|
|
2021
Q4 | – | Sell |
-1,715
| Closed | -$707K | – | 1609 |
|
|
2021
Q3 | $707K | Buy |
1,715
+550
| +47% | +$227K | ﹤0.01% | 1406 |
|
|
2021
Q2 | $431K | Buy |
+1,165
| New | +$431K | ﹤0.01% | 1493 |
|
|
2019
Q3 | – | Sell |
-8,420
| Closed | -$1.2M | – | 1430 |
|
|
2019
Q2 | $1.2M | Buy |
+8,420
| New | +$1.2M | 0.01% | 853 |
|